Alerts will be sent to your verified email
Verify Email
VINEETLAB
|
Vineet Laboratories
|
Onyx Biotec
|
Samrat Pharmachem
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
6.82 % | 13.47 % | 18.86 % |
|
5yr average Equity Multiplier
|
4.27 | 2.51 | 1.83 |
|
5yr Average Asset Turnover Ratio
|
1.52 | 0.82 | 2.61 |
|
5yr Avg Net Profit Margin
|
-4.28 % | 6.72 % | 3.87 % |
|
Price to Book
|
4.57 | 0.0 | 0.98 |
|
P/E
|
0.0 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
179.8 Days | 36.81 Days | 58.79 Days |
|
Inventory Days
|
114.74 Days | 48.71 Days | 28.98 Days |
|
Days Receivable
|
109.14 Days | 104.89 Days | 80.32 Days |
|
Days Payable
|
115.29 Days | 101.26 Days | 46.76 Days |
|
5yr Average Interest Coverage Ratio
|
1.29 | 4.89 | 16.47 |
|
5yr Avg ROCE
|
-1.66 % | 12.63 % | 27.43 % |
|
5yr Avg Operating Profit Margin
|
-0.62 % | 14.14 % | 5.58 % |
|
5 yr average Debt to Equity
|
1.24 | 0.95 | 0.21 |
|
5yr CAGR Net Profit
|
n/a | 8.12 % | 5.93 % |
|
5yr Average Return on Assets
|
-2.52 % | 5.64 % | 10.3 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
5.98 % | 65.1 % | 49.09 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-32.68 % | 0.0 | 0.45 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Vineet Laboratories
|
Onyx Biotec
|
Samrat Pharmachem
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|